期刊文献+

氯化钙浓度对念珠菌溶血活性的影响

Influence of concentrations of CaCl_(2)on hemolytic activity of candida strains
下载PDF
导出
摘要 目的通过将固定浓度的念珠菌菌悬液分别滴加到含有不同浓度CaCl_2的羊血培养基上培养,观察念珠菌溶血活性的差异,评估CaCl_2对念珠菌溶血活性的影响。方法选择25株念珠菌,其中包括21株临床分离株和4株标准株,配制4个不同浓度CaCl_2的羊血培养基,分别为0%、0.5%、1%和2.5%(g/m L),于37℃、5%体积分数CO_2培养。观察24 h、48 h、72 h的溶血反应并拍照、记录。结果念珠菌在不同浓度CaCl_2的羊血培养基中的溶血指数存在差异,差异具有统计学意义(F=24.929,P<0.001)。其中不含CaCl_2的溶血指数为2.749±0.103,含0.5%、1%和2.5%依次为2.247±0.079、2.013±0.092和2.150±0.066。结论不同浓度的CaCl_2会影响羊血培养基上念珠菌的溶血活性。 Objective To investigate the influence of different concentrations of CaCl2on the hemolytic activity of candida strains.Methods A total of25candida strains were selected,including21candida strains recovered from clinical specimens,and4reference strains of C.albicans(ATCC90028)(American Type Culture Collection,Manassas,VA,USA),C.glabrata(ATCC90030),C.krusei(ATCC6258),and C.tropicalis(ATCC13803)respectively.CaCl2was added at concentrations of0%,0.5%,1%and2.5g%(wt/vol).Plates were cultured at37℃in a5%CO2atmosphere for24?72h,and the hemolytic index(Hi)was analyzed.Results Comparsions of the hemolytic indices among the groups treated with0.5%CaCl2(Hi=2.247±0.079),1%CaCl2(Hi=2.013±0.092),2.5%CaCl2(Hi=2.150±0.066)and the control(Hi=2.749±0.103)reached statistical significance(P<0.001).Conclusion CaCl2may produce a decrease activity in the hemolysis of candida species.
作者 万蕾 卢海宾 罗刚 WAN Lei;LU Haibin;LUO Gang(Department of Periodontology and Implantology, Stomatological Hospital, Southern Medical University, Guangzhou 510280, China;Key Laboratory of Oral Medicine, Guangzhou Institute of Oral Disease, Stomatology Hospital of Guangzhou Medicial University, Guangzhou 510140, China)
出处 《口腔疾病防治》 2017年第8期494-497,共4页 Journal of Prevention and Treatment for Stomatological Diseases
基金 广东省自然科学基金(2014A030310146) 广东省医学科学技术研究基金(A2016241)
关键词 念珠菌 毒力因素 溶血活性 电解质 氯化钙 Candida species Virulence factors Hemolytic activity Electrolytes CaCl_(2)
  • 相关文献

参考文献1

二级参考文献11

  • 1周菊芬,徐岩英.口腔念珠菌混合带菌及感染的研究[J].现代口腔医学杂志,2004,18(4):329-331. 被引量:8
  • 2Phillips AN, Pradier C, Lazzarin A, et ah Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral experienced patients. AIDS, 2001,15 ( 18 ) : 2385-2395.
  • 3Anonymous. 1993 revised classification system for HIV infection and expanded surveillance case difinition for AIDS among adolescents and aduhs. MMWR Recomm Rep, 1992,41 ( RR-17 ) : 1-19.
  • 4Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of ca- PLB1, a Phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem, 1998,273 (40) :26078-26086.
  • 5Samaranayake YH, Dassanayake RS, Jayatilake JA, et al. Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection. J Med Microbiol, 2005,54( Pr 6) :583- 593.
  • 6Ribeiro MA, Miranda AE, Gambale W, et al. Prevalence and exoenzyme secretion by Candida albicans isolates from oral and vaginal mucosas of HIV-infected women. Mycopathologia, 2004, 157 (3) : 255-261.
  • 7Ghate M, Deshpande S, Tripathy S, et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis, 2009,13( 1 ) :e1-8.
  • 8Delgado AC, de Jesus Pedro R, Aoki FH, et al. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization. Clin Microbiol Infect, 2009,15 (4) : 364-371.
  • 9Back-Brito GN, Mota A J, Vasconcellos TC, et al. Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. Mycopathologia, 2009,167 ( 2 ) : 81-87.
  • 10Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata: an emerging oral opportunistic pathogen. J Dent Res, 2007,86 (3) : 204-215.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部